"10.1371_journal.pone.0029478","plos one","2011-12-22T00:00:00Z","Joan M Henriksen Hellyer; Aaron S DeVries; Sarah M Jenkins; Kandace A Lackore; Katherine M James; Jeanette Y Ziegenfuss; Gregory A Poland; Jon C Tilburt","Program in Professionalism and Ethics, Mayo Clinic, Rochester, Minnesota, United States of America; Infectious Disease, Epidemiology, Prevention and Control Division, Minnesota Department of Health, St. Paul, Minnesota, United States of America; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America; Biomedical Ethics Research Unit, Mayo Clinic, Rochester, Minnesota, United States of America; Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota, United States of America; Survey Research Center, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Mayo Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America; Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America","Conceived and designed the experiments: JMH ASD GAP JCT. Performed the experiments: JMH KMJ JCT. Analyzed the data: SMJ KAL KMJ JYZ. Contributed reagents/materials/analysis tools: JYZ. Wrote the paper: JMH ASD JYZ JCT KMJ.","Gregory A. Poland: GAP has offered consultative advice on novel influenza vaccine development to Merck & Co., Inc., Avianax, Theraclone Sciences (formally Spaltudaq Corporation), MedImmune LLC, Liquidia Technologies, INc., Novavax, Sanofi Pasteur, and PAXVAX, Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","12","Joan M Henriksen Hellyer","JMHH",8,TRUE,4,3,4,5,TRUE,FALSE,FALSE,0,NA,FALSE
